ReviewHereditary cancer in clinical practice2021

Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?

Alberto Fresa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.